BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Credit Suisse 2013 Healthcare Conference in Phoenix, Arizona on Wednesday, November 13, 2013 at 3:30 p.m. MST.
Help employers find you! Check out all the jobs and post your resume.
